These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31792870)

  • 21. Managing HIV-infected patients on antiretroviral therapy in Rio de Janeiro, Brazil: do providers follow national guidelines?
    Loo VS; Diaz T; Gadelha AM; Campos DP; Pilloto JH; Brandao PS; Grinsztejin B; Veloso dos Santos VG
    AIDS Care; 2004 Oct; 16(7):834-40. PubMed ID: 15385238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
    Tourret J; Tostivint I; Tézenas Du Montcel S; Karie S; Launay-Vacher V; Vigneau C; Bessette C; Deray G; Bagnis CI
    Clin Infect Dis; 2007 Sep; 45(6):779-84. PubMed ID: 17712764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus.
    Navarro J; Santos JR; Silva A; Burgos J; Falcó V; Ribera E; Imaz A; Curran A
    Pharmacotherapy; 2019 Apr; 39(4):501-507. PubMed ID: 30723941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
    Letendre S; Marquie-Beck J; Capparelli E; Best B; Clifford D; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Morgello S; Simpson D; Grant I; Ellis RJ;
    Arch Neurol; 2008 Jan; 65(1):65-70. PubMed ID: 18195140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A National HIV Provider Survey of Antiretroviral Therapy Preferences for Management of Treatment-Naive and Experienced Individuals With Drug Resistance.
    Krishnan S; Lippincott CK; Bjerrum S; Martinez Rivera MB; Shah M
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad541. PubMed ID: 38023561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.
    Tashima KT; Mollan KR; Na L; Gandhi RT; Klingman KL; Fichtenbaum CJ; Andrade A; Johnson VA; Eron JJ; Smeaton L; Haubrich RH
    HIV Clin Trials; 2015 Aug; 16(4):147-56. PubMed ID: 26212575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-efficacy comparison among three antiretroviral regimens in HIV-1 infected, treatment-experienced patients.
    Ruof J; Dusek A; DeSpirito M; Demasi RA
    Clin Drug Investig; 2007; 27(7):469-79. PubMed ID: 17563127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance with clinical guidelines and adherence to antiretroviral therapy among patients living with HIV.
    Tandon N; Mao J; Shprecher A; Anderson AJ; Cao F; Jiao X; Brown K
    Curr Med Res Opin; 2019 Jan; 35(1):63-71. PubMed ID: 30173561
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.
    Mendoza Y; Castillo Mewa J; Martínez AA; Zaldívar Y; Sosa N; Arteaga G; Armién B; Bautista CT; García-Morales C; Tapia-Trejo D; Ávila-Ríos S; Reyes-Terán G; Bello G; Pascale JM
    PLoS One; 2016; 11(4):e0154317. PubMed ID: 27119150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens.
    Montaner JS; Harrigan PR; Jahnke N; Raboud J; Castillo E; Hogg RS; Yip B; Harris M; Montessori V; O'Shaughnessy MV
    AIDS; 2001 Jan; 15(1):61-9. PubMed ID: 11192869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
    Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P
    HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and durability of nevirapine in antiretroviral drug näive patients.
    Lange JM
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S40-52. PubMed ID: 14562857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The successful application of a national peer advisory committee for physicians who provide salvage regimens to heavily antiretroviral-experienced patients in mexican human immunodeficiency virus clinics.
    Calva JJ; Sierra-Madero J; Soto-Ramírez LE; Aguilar-Salinas P
    Open Forum Infect Dis; 2014 Sep; 1(2):ofu081. PubMed ID: 25734149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care.
    Brouwer ES; Napravnik S; Smiley SG; Corbett AH; Eron JJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):432-9. PubMed ID: 21294218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
    Smith RJ; Okano JT; Kahn JS; Bodine EN; Blower S
    Science; 2010 Feb; 327(5966):697-701. PubMed ID: 20075214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Decline in HIV-1 Drug Resistance in Heavily Antiretroviral-Experienced Patients Is Associated with Optimized Prescriptions in a Treatment Roll-Out Program in Mexico.
    Calva JJ; Larrea S; Tapia-Maltos MA; Ostrosky-Frid M; Lara C; Aguilar-Salinas P; Rivera H; Ramírez JP
    AIDS Res Hum Retroviruses; 2017 Jul; 33(7):675-680. PubMed ID: 28094565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.
    Carmody ER; Diaz T; Starling P; dos Santos AP; Sacks HS
    Trop Med Int Health; 2003 May; 8(5):378-85. PubMed ID: 12753630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost of antiretroviral drug resistance in HIV-positive patients.
    Krentz HB; Ko K; Beckthold B; Gill MJ
    Antivir Ther; 2014; 19(4):341-8. PubMed ID: 24296618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using computer-based monitoring and intervention to prevent harmful combinations of antiretroviral drugs in the New York State AIDS Drug Assistance Program.
    Gonzalez CJ; Rivera CA; Martin RJ; Mergian GA; Cruz H; Agins BD
    Jt Comm J Qual Patient Saf; 2012 Jun; 38(6):269-76. PubMed ID: 22737778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.